Odinwell AB is a medtech company with a patented optical technology for assessment of covered wounds.
n/a
Last FY Revenue n/a
Last FY EBITDA -$0.4M
$1.3M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Odinwell achieved revenue of n/a and an EBITDA of -$0.4M.
Odinwell expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Odinwell valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | n/a | XXX | XXX | XXX |
Gross Profit | XXX | $0.5M | XXX | XXX | XXX |
Gross Margin | XXX | n/a | XXX | XXX | XXX |
EBITDA | XXX | -$0.4M | XXX | XXX | XXX |
EBITDA Margin | XXX | n/a | XXX | XXX | XXX |
EBIT | XXX | -$0.7M | XXX | XXX | XXX |
EBIT Margin | XXX | n/a | XXX | XXX | XXX |
Net Profit | XXX | -$0.6M | XXX | XXX | XXX |
Net Margin | XXX | n/a | XXX | XXX | XXX |
Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 3, 2025, Odinwell's stock price is SEK 0 (or $0).
Odinwell has current market cap of SEK 15.8M (or $1.7M), and EV of SEK 12.5M (or $1.3M).
See Odinwell trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$1.3M | $1.7M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 3, 2025, Odinwell has market cap of $1.7M and EV of $1.3M.
Odinwell's trades at n/a EV/Revenue multiple, and -3.0x EV/EBITDA.
Equity research analysts estimate Odinwell's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Odinwell's P/E ratio is not available.
See valuation multiples for Odinwell and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $1.7M | XXX | $1.7M | XXX | XXX | XXX |
EV (current) | $1.3M | XXX | $1.3M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | n/a | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | -3.0x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | -1.9x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | -3.0x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -1.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialOdinwell's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Odinwell's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Odinwell's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Odinwell and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Odinwell acquired XXX companies to date.
Last acquisition by Odinwell was XXXXXXXX, XXXXX XXXXX XXXXXX . Odinwell acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhere is Odinwell headquartered? | Odinwell is headquartered in Sweden. |
Is Odinwell publicy listed? | Yes, Odinwell is a public company listed on SAT. |
What is the stock symbol of Odinwell? | Odinwell trades under ODIN ticker. |
When did Odinwell go public? | Odinwell went public in 2021. |
Who are competitors of Odinwell? | Similar companies to Odinwell include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
What is the current market cap of Odinwell? | Odinwell's current market cap is $1.7M |
Is Odinwell profitable? | Yes, Odinwell is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.